| Primary |
| Medication Dilution |
26.7% |
| Spider Vein |
16.7% |
| Antibiotic Therapy |
6.7% |
| Cerebral Infarction |
6.7% |
| Emphysema |
6.7% |
| Lung Infection |
6.7% |
| Colonic Polyp |
3.3% |
| Dehydration |
3.3% |
| Enteritis |
3.3% |
| Fluid Replacement |
3.3% |
| Hydrocephalus |
3.3% |
| Pain |
3.3% |
| Prophylaxis |
3.3% |
| Tonsillitis |
3.3% |
| Vasospasm |
3.3% |
|
| Anaphylactoid Reaction |
10.7% |
| Anaphylactic Shock |
7.1% |
| Blister |
7.1% |
| Death |
7.1% |
| Injection Site Reaction |
7.1% |
| Pneumonia |
7.1% |
| Vomiting |
7.1% |
| Cardiac Failure |
3.6% |
| Chest Discomfort |
3.6% |
| Chills |
3.6% |
| Cystic Fibrosis |
3.6% |
| Drug Ineffective |
3.6% |
| Dyspnoea |
3.6% |
| Heart Rate Increased |
3.6% |
| Hyperhidrosis |
3.6% |
| Hypersensitivity |
3.6% |
| Hypotension |
3.6% |
| Impaired Healing |
3.6% |
| Injection Site Discolouration |
3.6% |
| Injection Site Pallor |
3.6% |
|
| Secondary |
| Drug Use For Unknown Indication |
19.0% |
| Pain |
9.6% |
| Sleep Disorder |
7.0% |
| Hypertension |
6.4% |
| Infection Prophylaxis |
6.1% |
| Coronary Artery Disease |
5.8% |
| Fluid Replacement |
5.3% |
| Prophylaxis |
5.3% |
| Oedema |
3.5% |
| Thrombosis Prophylaxis |
3.5% |
| Product Used For Unknown Indication |
3.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.2% |
| Antibiotic Therapy |
2.9% |
| Cardiac Failure |
2.9% |
| Immunosuppressant Drug Therapy |
2.9% |
| Mineral Supplementation |
2.9% |
| Pneumonia |
2.9% |
| Nausea |
2.6% |
| Cystitis |
2.3% |
| Endoscopic Retrograde Cholangiopancreatography |
2.3% |
|
| Toxic Epidermal Necrolysis |
19.6% |
| Bacteraemia |
17.9% |
| Drug Ineffective |
8.9% |
| Catheter Thrombosis |
7.1% |
| Stevens-johnson Syndrome |
7.1% |
| Serratia Infection |
5.4% |
| Anaphylactoid Reaction |
3.6% |
| Diarrhoea |
3.6% |
| Pneumothorax |
3.6% |
| Swollen Tongue |
3.6% |
| Vomiting |
3.6% |
| Adverse Drug Reaction |
1.8% |
| Anaphylactic Shock |
1.8% |
| Hypernatraemia |
1.8% |
| Hypersensitivity |
1.8% |
| Hypotension |
1.8% |
| Medication Error |
1.8% |
| Nephrogenic Diabetes Insipidus |
1.8% |
| Pain |
1.8% |
| Renal Failure Acute |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.1% |
| Drug Use For Unknown Indication |
18.8% |
| Prophylaxis |
5.5% |
| Diarrhoea |
4.6% |
| Nausea |
4.2% |
| Gastrooesophageal Reflux Disease |
3.4% |
| Neoplasm |
3.4% |
| Pain |
3.2% |
| Vomiting |
2.6% |
| Ill-defined Disorder |
2.2% |
| Constipation |
2.0% |
| Hypertension |
2.0% |
| Thrombosis Prophylaxis |
1.9% |
| Hypomagnesaemia |
1.8% |
| Hypokalaemia |
1.7% |
| Transfusion |
1.7% |
| Abdominal Distension |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Fluid Replacement |
1.4% |
| Anxiety |
1.3% |
|
| Vomiting |
18.3% |
| Enterocolitis |
11.0% |
| Anaemia |
6.1% |
| Convulsion |
6.1% |
| Paraesthesia Oral |
6.1% |
| Somnolence |
6.1% |
| Nausea |
4.9% |
| Purpura |
4.9% |
| Dyspnoea |
3.7% |
| Gastrointestinal Pain |
3.7% |
| Headache |
3.7% |
| Rash |
3.7% |
| Shock |
3.7% |
| Skin Tightness |
3.7% |
| Abdominal Distension |
2.4% |
| Agranulocytosis |
2.4% |
| Fatigue |
2.4% |
| Febrile Neutropenia |
2.4% |
| Hypothermia |
2.4% |
| Infusion Related Reaction |
2.4% |
|
